← Scroll for more →
Financial Statements — CCTG
Balance Sheet
(in millions USD)| Metric | Q4 2026 | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Cash & Equivalents | 4.09 | 2.81 | 3.69 | 4.00 | 5.53 |
| Accounts Receivable | 2.83 | 2.80 | 2.50 | 3.26 | 2.75 |
| Inventory | 2.30 | 1.92 | 1.76 | 1.97 | 2.02 |
| Total Current Assets | 10.91 | 8.56 | 9.02 | 10.96 | 11.98 |
| Property, Plant & Equipment | 1.98 | 0.82 | 0.85 | 0.68 | 0.20 |
| Intangible Assets | 0.07 | 0.10 | 0.08 | 0.10 | 0.04 |
| Total Non-current Assets | 7.38 | 6.68 | 6.31 | 6.46 | 5.96 |
| Total Assets | 18.29 | 15.24 | 15.33 | 17.43 | 17.94 |
| Accounts Payable | 2.78 | 2.39 | 1.82 | 2.57 | 2.18 |
| Total Current Liabilities | 5.21 | 4.65 | 3.84 | 4.60 | 4.44 |
| Long-term Debt | -- | -- | -- | 0.46 | 3.60 |
| Total Non-current Liabilities | 0.39 | 0.60 | 0.76 | 0.97 | 1.20 |
| Total Liabilities | 5.60 | 5.26 | 4.60 | 5.58 | 5.64 |
| Retained Earnings | 2.28 | 6.11 | 7.08 | 7.75 | 8.49 |
| Total Stockholder Equity | 12.69 | 9.98 | 10.73 | 11.85 | 12.30 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Total Revenue | 8.47 | 9.22 |
| Cost of Revenue | 5.99 | 6.47 |
| Gross Profit | 2.48 | 2.75 |
| Research & Development | 0.33 | 0.33 |
| Selling, General & Admin | 2.44 | 2.47 |
| Total Operating Expenses | 3.44 | 3.55 |
| Operating Income | (0.96) | (0.81) |
| Pretax Income | (1.08) | (0.94) |
| Tax Provision | (0.11) | (0.19) |
| Net Income | (0.97) | (0.74) |
| Basic EPS | (0.08) | (0.06) |
| Diluted EPS | (0.08) | (0.06) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q2 2025 |
|---|---|---|
| Operating Cash Flow | (0.41) | (1.12) |
| Capital Expenditures | 0.01 | 0.04 |
| Free Cash Flow* | (0.42) | (1.17) |
| Investing Cash Flow | (0.48) | (0.67) |
| Financing Cash Flow | -- | (0.40) |
← Scroll for more columns →
* Derived from reported values